Li‐ping Gong

1.2k citations
43 papers · 717 indexed · h-index 16
Topics
Lymphoma Diagnosis and Treatment (13 papers)Viral-associated cancers and disorders (10 papers)RNA modifications and cancer (7 papers)

In The Last Decade

Li‐ping Gong

39 papers receiving 710 citations

Peers

Li‐ping Gong
Comparison fields: 5 of 84
  • Molecular Biology 311
  • Cancer Research 265
  • Oncology 199
  • Pathology and Forensic Medicine 128
  • Immunology 82
Replace Jian‐Ming Li with:
Jian‐Ming Li China
Mei Wu China
A Funakoshi Japan
Gema Robledo Spain
Roobina Boghozian Canada
Baosen Jia China
Shafiuddin Siddiqui United States
Pasquale Persico Italy
Weiming Mao United States
Bożena Szymańska Poland
Li‐ping Gong relative to Jian‐Ming Li China Jian‐Ming Li's profile →
Citations per field
00.5×3.0×
Jian‐Ming Li · 1×
Citations per year

Countries citing papers authored by Li‐ping Gong

Since Specialization
Citations

This map shows the geographic impact of Li‐ping Gong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li‐ping Gong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li‐ping Gong more than expected).

Fields of papers citing papers by Li‐ping Gong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li‐ping Gong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li‐ping Gong. The network helps show where Li‐ping Gong may publish in the future.

Co-authorship network of co-authors of Li‐ping Gong

This figure shows the co-authorship network connecting the top 25 collaborators of Li‐ping Gong. A scholar is included among the top collaborators of Li‐ping Gong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li‐ping Gong. Li‐ping Gong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 1
4 1
5 1
6 28
7 6
8 42
9 74
10 72
11 9
12 25
13 21
14 61
15
[Abnormality of anaplastic lymphoma kinase gene and its expression in pediatric neuroblastoma].
1
16 37
17 5
18 10
19 11
20 19

About Li‐ping Gong

Li‐ping Gong is a scholar working on Cancer Research, Pathology and Forensic Medicine and Behavioral Neuroscience, having authored 43 papers that have together received 717 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (13 papers), Viral-associated cancers and disorders (10 papers) and RNA modifications and cancer (7 papers). The work is most often cited by research in Cancer Research (265 citations), Endocrine and Autonomic Systems (57 citations) and Oncology (199 citations). Li‐ping Gong has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Chun‐Kui Shao, Jianning Chen, Jing Liang, Zhiying Feng, Min Dong, Jing Li, Yuhang Pan, Xiao Yu, Chunju Zhou and Dan He. Their work appears in journals such as Blood, Scientific Reports and Neuroscience.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026